Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Carroll

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Scientific Reports|December 11, 2020
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant diseaseRebecca Smith, Moqing Liu, Tiera Liby, et al.
European Urology Oncology|August 1, 2024
De-escalation of Monitoring in Active Surveillance for Prostate Cancer: Results from the GAP3 ConsortiumYoichiro Tohi, John M Sahrmann, Jaron Arbet, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 29, 2022
Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and MortalityCrystal S Langlais, Rebecca E Graff, Erin L Van Blarigan, et al.
The Journal of Urology|December 14, 2012
Prostate specific antigen best practice statement: 2009 updateKirsten L Greene, Peter C Albertsen, Richard J Babaian, et al.
The Journal of Urology|September 29, 2009
Prostate specific antigen best practice statement: 2009 updateKirsten L Greene, Peter C Albertsen, Richard J Babaian, et al.
European Urology Open Science|December 22, 2021
Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium DatabaseKerri Beckmann, Aida Santaolalla, Jozien Helleman, et al.
JAMA Oncology|April 1, 2016
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial BiopsyJames McKiernan, Michael J Donovan, Vince O'Neill, et al.
Journal of the National Cancer Institute|September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancerLawrence Fong, Peter Carroll, Vivian Weinberg, et al.
Cancer Research|June 5, 2003
Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumorsJoris A Veltman, Jane Fridlyand, Sunanda Pejavar, et al.
Urology|March 26, 2014
Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshopJonathan P Jarow, Ian M Thompson, Paul G Kluetz, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Scientific Reports|December 11, 2020
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant diseaseRebecca Smith, Moqing Liu, Tiera Liby, et al.
European Urology Oncology|August 1, 2024
De-escalation of Monitoring in Active Surveillance for Prostate Cancer: Results from the GAP3 ConsortiumYoichiro Tohi, John M Sahrmann, Jaron Arbet, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 29, 2022
Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and MortalityCrystal S Langlais, Rebecca E Graff, Erin L Van Blarigan, et al.
The Journal of Urology|December 14, 2012
Prostate specific antigen best practice statement: 2009 updateKirsten L Greene, Peter C Albertsen, Richard J Babaian, et al.
The Journal of Urology|September 29, 2009
Prostate specific antigen best practice statement: 2009 updateKirsten L Greene, Peter C Albertsen, Richard J Babaian, et al.
European Urology Open Science|December 22, 2021
Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium DatabaseKerri Beckmann, Aida Santaolalla, Jozien Helleman, et al.
JAMA Oncology|April 1, 2016
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial BiopsyJames McKiernan, Michael J Donovan, Vince O'Neill, et al.
Journal of the National Cancer Institute|September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancerLawrence Fong, Peter Carroll, Vivian Weinberg, et al.
Cancer Research|June 5, 2003
Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumorsJoris A Veltman, Jane Fridlyand, Sunanda Pejavar, et al.
Urology|March 26, 2014
Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshopJonathan P Jarow, Ian M Thompson, Paul G Kluetz, et al.
Pageof 8